MEDICINA
Departamento
Marc
Miravitlles
Publicaciones en las que colabora con Marc Miravitlles (41)
2024
-
Detection of Alpha-1 Antitrypsin Levels in Chronic Obstructive Pulmonary Disease in Respiratory Clinics in Spain: Results of the EPOCONSUL 2021 Audit
Journal of Clinical Medicine, Vol. 13, Núm. 4
2023
-
Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry
The European respiratory journal
-
Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry (Respiratory Research, (2022), 23, 1, (352), 10.1186/s12931-022-02275-4)
Respiratory Research
-
Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin
International Journal of COPD, Vol. 18, pp. 1691-1700
-
Variations in Chronic Obstructive Pulmonary Disease Outpatient Care in Respiratory Clinics: Results From the 2021 EPOCONSUL Audit
Archivos de Bronconeumologia, Vol. 59, Núm. 5, pp. 295-304
2022
-
Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
Respiratory Research, Vol. 23, Núm. 1
-
Demographic and clinical characteristics of patients with α1-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO
ERJ Open Research, Vol. 8, Núm. 3
-
Pulmonologists’ Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey
International Journal of COPD, Vol. 17, pp. 1577-1587
2021
-
Burden of disease among exacerbating patients with COPD treated with triple therapy in Spain
International Journal of COPD, Vol. 16, pp. 2149-2161
2020
-
Prevalence of α1-antitrypsin pizz genotypes in patients with copd in Europe: A systematic review
European Respiratory Review, Vol. 29, Núm. 157, pp. 1-7
-
Relationship between clinical control, respiratory symptoms and quality of life for patients with COPD
International Journal of COPD, Vol. 15, pp. 2683-2693
-
The Importance of Reference Centers and Registries for Rare Diseases: The Example of Alpha-1 Antitrypsin Deficiency
COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 17, Núm. 4, pp. 346-354
2019
-
Correction: Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: A Spanish National Healthcare System perspective (Respiratory Research (2018) 19 (224) DOI: 10.1186/s12931-018-0916-7)
Respiratory Research
-
Geographic distribution of COPD prevalence in the world displayed by Geographic Information System maps
The European respiratory journal
-
Geographic distribution of chronic obstructive pulmonary disease prevalence in Africa, Asia and Australasia
International Journal of Tuberculosis and Lung Disease, Vol. 23, Núm. 10, pp. 1100-1106
-
Patients with Chronic Obstructive Pulmonary Disease Exacerbations: Recommendations for Diagnosis, Treatment and Care
Archivos de Bronconeumologia, Vol. 55, Núm. 9, pp. 478-487
2018
-
Alpha-1 antitrypsin deficiency: Outstanding questions and future directions
Orphanet Journal of Rare Diseases, Vol. 13, Núm. 1
-
Evaluation of criteria for clinical control in a prospective, international, multicenter study of patients with COPD
Respiratory Medicine, Vol. 136, pp. 8-14
-
Factors affecting the selection of an inhaler device for COPD and the ideal device for different patient profiles. Results of EPOCA Delphi consensus
Pulmonary Pharmacology and Therapeutics, Vol. 48, pp. 97-103
-
Geographical Distribution of COPD Prevalence in the Americas
COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 15, Núm. 4, pp. 317-325